We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Danaher
DHR
$141B
| $556M | 0.21% |
4,084,749
-89,811
| -2% | -$11.3M |
|
102
Caterpillar
CAT
$395B
| $556M | 0.21% |
3,762,611
-364,153
| -9% | -$50.8M |
|
103
Vertex Pharmaceuticals
VRTX
$124B
| $550M | 0.21% |
2,513,072
+445,821
| +22% | +$90.2M |
|
104
Simon Property Group
SPG
$71.7B
| $545M | 0.21% |
3,660,653
+99,119
| +3% | +$14.9M |
|
105
Thermo Fisher Scientific
TMO
$215B
| $545M | 0.21% |
1,677,319
-144,937
| -8% | -$43.9M |
|
106
Eli Lilly
LLY
$1.05T
| $542M | 0.21% |
4,121,592
-2,740,499
| -40% | -$318M |
|
107
Gilead Sciences
GILD
$165B
| $540M | 0.2% |
8,304,080
-1,512,563
| -15% | -$98.5M |
|
|
MRSH
108
Marsh
MRSH
$91.4B
| $532M | 0.2% |
4,776,556
-58,381
| -1% | -$6.1M |
|
109
EOG Resources
EOG
$70.2B
| $521M | 0.2% |
6,224,727
-41,406
| -0.7% | -$3.03M |
|
110
Oracle
ORCL
$417B
| $520M | 0.2% |
9,818,888
+359,312
| +4% | +$19.8M |
|
|
AGN
111
DELISTED
Allergan plc
AGN
| $495M | 0.19% |
2,587,891
-319,745
| -11% | -$57.7M |
|
112
Sherwin-Williams
SHW
$89.6B
| $488M | 0.19% |
2,507,949
-193,326
| -7% | -$36.9M |
|
113
American International
AIG
$41.7B
| $488M | 0.18% |
9,497,489
-955,304
| -9% | -$50.6M |
|
|
FISV
114
Fiserv Inc
FISV
$28.1B
| $477M | 0.18% |
4,123,384
+14,909
| +0.4% | +$1.65M |
|
115
3M
MMM
$93.3B
| $476M | 0.18% |
3,225,454
-2,707
| -0.1% | -$379K |
|
116
CSX Corp
CSX
$93.4B
| $475M | 0.18% |
19,693,050
-3,910,044
| -17% | -$92.5M |
|
117
Deere & Co
DE
$167B
| $467M | 0.18% |
2,697,131
-282,572
| -9% | -$48.7M |
|
118
Lam Research
LRCX
$389B
| $467M | 0.18% |
15,962,610
-11,023,560
| -41% | -$293M |
|
119
Advanced Micro Devices
AMD
$795B
| $459M | 0.17% |
10,003,091
-786,058
| -7% | -$28.9M |
|
120
Colgate-Palmolive
CL
$73.9B
| $452M | 0.17% |
6,562,339
-7,786
| -0.1% | -$531K |
|
121
United Parcel Service
UPS
$88.4B
| $449M | 0.17% |
3,839,031
+198,544
| +5% | +$23.5M |
|
122
Crown Castle
CCI
$32.1B
| $447M | 0.17% |
3,145,078
-29,567
| -0.9% | -$4.03M |
|
123
AvalonBay Communities
AVB
$26.6B
| $445M | 0.17% |
2,120,626
-147,926
| -7% | -$31.7M |
|
124
Dow Inc
DOW
$21.2B
| $437M | 0.17% |
7,982,142
+4,162,438
| +109% | +$215M |
|
125
Dominion Energy
D
$58.3B
| $432M | 0.16% |
5,211,998
+85,897
| +2% | +$7.02M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.